APA

Judkins T., Hendrickson B. C., Deffenbaugh A. M., Eliason K., Leclair B., Norton M. J., Ward B. E., Pruss D. & Scholl T. (20051222). Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations. : Cancer research.

Chicago

Judkins Thaddeus, Hendrickson Brant C, Deffenbaugh Amie M, Eliason Kristilyn, Leclair Benoît, Norton Michael J, Ward Brian E, Pruss Dmitri and Scholl Thomas. 20051222. Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations. : Cancer research.

Harvard

Judkins T., Hendrickson B. C., Deffenbaugh A. M., Eliason K., Leclair B., Norton M. J., Ward B. E., Pruss D. and Scholl T. (20051222). Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations. : Cancer research.

MLA

Judkins Thaddeus, Hendrickson Brant C, Deffenbaugh Amie M, Eliason Kristilyn, Leclair Benoît, Norton Michael J, Ward Brian E, Pruss Dmitri and Scholl Thomas. Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations. : Cancer research. 20051222.